Publikationen, an denen er mitarbeitet OLATZ IZAOLA JAUREGUI (51)

2015

  1. Efectos de un suplemento hipercalórico e hiperprotéico enriquecida con ácidos grasos w3 y fibra en pacientes ambulatorios postquirúrgicos con cáncer de cabeza y cuello

    Nutricion Hospitalaria, Vol. 31, Núm. 2, pp. 759-763

  2. Effect of three different doses of arginine enhanced enteral nutrition on nutritional status and outcomes in well nourished postsurgical cancer patients: a randomized single blinded prospective trial

    European review for medical and pharmacological sciences, Vol. 19, Núm. 6, pp. 950-955

2013

  1. A randomized clinical trial with two doses of a omega 3 fatty acids oral and arginine enhanced formula in clinical and biochemical parameters of head and neck cancer ambulatory patients

    European Review for Medical and Pharmacological Sciences, Vol. 17, Núm. 8, pp. 1090-1094

  2. A randomized clinical trial with two doses of an enteral diabetes-specific suplements in elderly patients with diabetes mellitus type 2

    European Review for Medical and Pharmacological Sciences, Vol. 17, Núm. 12, pp. 1626-1630

  3. Association of anthropometric and biochemical markers with length of stay and mortality in the hospital

    European Review for Medical and Pharmacological Sciences, Vol. 17, Núm. 10, pp. 1321-1325

  4. Efectos de una fórmula nutricional en polvo enriquecidad con w3 en pacientes ambulatorios postquirúrgicos con cáncer de cabeza y cuello

    Nutricion Hospitalaria, Vol. 28, Núm. 5, pp. 1463-1467

  5. Experience over 12 years with home enteral nutrition in a healthcare area of Spain

    Journal of Human Nutrition and Dietetics, Vol. 26, Núm. SUPPL.1, pp. 39-44

  6. Micronutrient status in morbidly obese women before bariatric surgery

    Surgery for Obesity and Related Diseases, Vol. 9, Núm. 2, pp. 323-327

2011

  1. Resistin levels in morbid obese patients following the biliopancreatic diversion surgery

    Hormone and Metabolic Research, Vol. 43, Núm. 3, pp. 205-208

  2. Zinc and Copper Serum Levels of Morbidly Obese Patients Before and After Biliopancreatic Diversion: 4 Years of Follow-up

    Journal of Gastrointestinal Surgery, Vol. 15, Núm. 12, pp. 2178-2181

2010

  1. A randomized double-blind clinical trial with two different doses of arginine enhanced enteral nutrition in postsurgical cancer patients

    European Review for Medical and Pharmacological Sciences, Vol. 14, Núm. 11, pp. 941-945

  2. G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion

    European Review for Medical and Pharmacological Sciences, Vol. 14, Núm. 3, pp. 197-201

  3. Influence of G308A polymorphism of tumor necrosis factor alpha gene on surgical results of biliopancreatic diversion

    Obesity Surgery, Vol. 20, Núm. 2, pp. 221-225

  4. Influence of Lys656asn polymorphism of leptin receptor gene on surgical results of biliopancreatic diversion

    Journal of Gastrointestinal Surgery, Vol. 14, Núm. 5, pp. 899-903

  5. Influence of an immuno-enhanced formula in postsurgical ambulatory patients with head and neck cancer

    Nutricion Hospitalaria, Vol. 25, Núm. 5, pp. 793-796

2009

  1. Efecto de una dieta con productos modificados de textura en pacientes ancianos ambulatorios

    Nutricion Hospitalaria, Vol. 24, Núm. 1, pp. 87-92

  2. Efecto de una fórmula enteral enriquecida en arginina sobre los marcadores inflamatorios en pacientes con tumores de cabeza y cuello

    Medicina Clinica, Vol. 132, Núm. 2, pp. 49-52

  3. High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial

    European Review for Medical and Pharmacological Sciences, Vol. 13, Núm. 4, pp. 279-283

2008

  1. A randomized clinical trial with two enteral diabetes-specific supplements in patients with diabetes mellitus type 2: Metabolic effects

    European Review for Medical and Pharmacological Sciences, Vol. 12, Núm. 4, pp. 261-266

  2. A randomized clinical trial with two omega 3 fatty acid enhanced oral suplements in head and neck cancer ambulatory patients

    European Review for Medical and Pharmacological Sciences, Vol. 12, Núm. 3, pp. 177-181